Trimetazidine Actavis

Medicinal product

(Invented) name

Trimetazidine Actavis

Active substance (s)

Trimetazidino dihidrochloridas

Strength

35 mg

Pharmaceutical form

modifikuoto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C01EB15, Trimetazidine

Marketing authorisation holder

Teva B.V., Nyderlandai

Date of authorisation

2010-08-13

Date of renewal

2020-09-30

Documents

2146 Trimetazidine Actavis PCS PL 2024 07 23.docx

2146 Pakuotės lapelis 2024 07 23.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

HU/H/0595/001

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Trimetazidino dihidrochloridas	35 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
34090	36445	1036445	lizdinė plokštelė	N60		Receptinis	LT/1/10/2146/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-09-29	Išregistruotas
2020-09-30	Perregistruotas
2015-07-28	Perregistruotas
2010-08-13	Registruotas